Table 2 Correlation between RARRES1/AGBL2 expression and clinicopathological features of RCC analysed by Chi-square test.

From: Expression of RARRES1 and AGBL2 and progression of conventional renal cell carcinoma

 

No. of cases (691)

RARRES1/AGBL2 expression

p Value

 

neg, cyt/− (168)

neg, cyt/+ (69)

mem/− (344)

mem/+ (110)

Gender

     

0.002

 Male

406

115

48

185

58

 

 Female

285

53

21

159

52

 

Status

     

<0.001

 AWD

579

106

38

327

109

 

 PTR

112

62

31

17

1

 

Size, cm

     

<0.001

 <4

272

31

14

161

66

 

 4–7

269

73

33

128

35

 

 >7

150

64

22

55

9

 

T

     

<0.001

 pT1

511

89

36

286

100

 

 pT2

94

30

11

47

6

 

 pT3

86

49

22

11

4

 

Necrosis

      

 No

608

132

45

323

108

<0.001

 Yes

83

36

24

21

2

 

Grade

     

<0.001

 G1

456

76

18

279

83

 

 G2

180

63

32

59

26

 

 G3

55

29

19

6

1

 

Stage

     

<0.001

 I

504

88

35

282

99

 

 II

167

71

31

57

8

 

 III

20

9

3

5

3

 
  1. PTR postoperative tumour relapse.
Back to article page